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ABSTRACT 
DEVELOPMENT OF HIGHLY LUMINESCENT AND WATER-DISPERSIBLE 
LANTHANIDE-BASED NANOMATERIALS FOR POTENTIAL BIO-MEDICAL 
IMAGING 
Gayanthi Kumari Attanayake  
Western Carolina University (April 2013) 
Director: Assistant Professor Channa R. De Silva 
 
Lanthanide metal ions exhibit fascinating optical and magnetic properties.  
Lanthanide-based nanomaterials have potential applications in optical devices, 
telecommunication, electroluminescent devices, bio-analytical sensors, and bio-medical 
imaging technology.  Despite the recent developments, low luminescence characteristics, 
poor water solubility, and poor cell selectivity of lanthanide-based materials limit their 
use in bio-medical applications. This project is designed to mainly improve the 
luminescence properties of Eu(III)-based nanomaterials for their potential use in 
biomedical applications.  In addition, we explore synthetic methods to enhance the water 
dispersibility and melanoma cell selectivity of the nanoparticles.  Current research is 
designed to address the above mentioned drawbacks of lanthanide-based nanomaterials.  
Two different nanoparticle systems were developed in this project.  i. europium (Eu)-
based down-converting nanoparticles, ii. ytterbium (Yb)- erbium (Er)-based upconverting 
nanoparticles.     
Many down-converting nanoparticle systems suffer from low-luminescence 
efficiencies due to their poor light absorption by direct excitation of the lanthanide ions. 
2 
 
In order to improve the luminescence characteristics, we have designed a novel 
nanomaterial by surface-coating it with organic chromophores having strong light 
absorption properties.  LaEuF3.AEP (La=lanthanum, AEP = aminoethyl phosphate) 
nanoparticles were successfully synthesized using a low temperature heating method and 
Eu-based NaYF4 nanoparticles were synthesized using a high temperature heating 
method.  A ligand exchange procedure was developed to functionalize the surface of the 
nanoparticles with an organic chromophore, TTA (thenoyltrifluoroacetone).  The TTA 
functionalized Eu(III)-based nanoparticles exhibit impressive luminescence 
enhancements utilizing the sensitization effect.  
Poor water solubility is the main drawback of the upconverting nanoparticles for 
bio-medical applications.  We have optimized a ligand exchange procedure to 
functionalize nanoparticle surface by using water soluble and highly coordinative 
aminoethyl phosphate (AEP) ligand.  Water soluble AEP coated Yb- and Er-doped 
NaYF4 upconverting nanoparticles were prepared using high temperature method. 
              The synthesized nanoparticles were characterized using UV-visible absorption, 
Fourier transform infrared (FT-IR), and fluorescence spectroscopic techniques, X-ray 
powder diffraction (XRD), thermogravimetric analysis (TGA) and electron microscope 
techniques (TEM and SEM).  Luminescent quantum yields of the down-converting 
nanoparticles were enhanced due to surface modification.  The luminescence lifetime 
studies and luminescence enhancement of the nanoparticles will be discussed with an 
emphasis on their potential use in biomedical applications.  
3 
 
  Our attempts to improve the selectivity of the nanoparticles will be discussed 
where the nanoparticles were labeled with a melanocortin stimulating hormone (MSH4) 
peptide ligand targeted to human melanocortin receptors (hMCRs). Once fully developed, 
the nanoparticle platform has potential use in screening melanoma cancer cell surface-
selective biomolecules and in vivo imaging of melanoma cancer. 
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CHAPTER 1 
INTRODUCTION 
1.1 BACKGROUND 
Luminescent nanomaterials in the form of nanoparticles, nanorods, nanowires, 
nanotubes, as well as colloidal or bulk nanocrystals are of interest for several applications 
including light emitting diodes, laser technology, telecommunication, sensor applications,  
cell-based luminescence assays, and medical diagnostics including cancer imaging.
1
  
Nanomaterials (with nanometer-sized dimensions) have impressive optical properties 
compared to those observed for their macroscopic materials (millimeter-sized 
dimensions).  This phenomenon increases their recent attention among the scientific 
community towards nano-biotechnological applications.
2
 In recent years, luminescent 
lanthanide-based nanoparticles have found novel uses in diverse biomedical applications 
including whole cell binding assays and cancer imaging.
3 
           Historically, a wide variety of organic fluorescent reagents including fluorescein 
and rhodamine has been used as biological labels.  These dye molecules have been 
synthesized with functional terminals for the attachment of selective protein molecules 
for targeted imaging.  Despite the successful use of organic dyes for cellular imaging, 
organic dyes limit their in vivo applications due to broad emission bands, fast 
photobleaching, and short luminescence lifetimes.  Rapid photobleaching of organic dyes 
(within 10 to 15 minutes) limit their use in time-dependent imaging experiments.  Their 
short fluorescence lifetimes (1-100 ns) correlate with short-lived natural fluorescent 
5 
 
background found in biological samples and limit their use with proteins in the nano-
molar binding range.
4
       
           Luminescent lanthanide metal ions, on the other hand, have many characteristics 
making them attractive candidates for biological applications.  Lanthanide metal ions 
have well-defined and narrow (line-like) emission bands with large Stokes shifts (up to 
300 nm) (Figure 1.1).  The unique luminescence characteristics of lanthanide metal ions 
result from their 4f electronic configurations which are shielded by the filled 5s and 
5p sub-shells.
5, 6
  Due to large Stokes shifts and narrow emission peaks, lanthanide ions 
can be used as multi-probes for biological measurements.  Lanthanide ions exhibit 
limited photo-bleaching, higher chemical stability than that of organic dyes and long 
luminescence lifetimes, mostly in the visible and near infrared regions of the 
electromagnetic spectrum.
7
 
 
 
Figure 1.1. Narrow emission peaks and Stokes shift of Eu
3+
 ion.             
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 Longer luminescence lifetimes of lanthanide ions promise a higher signal-to-noise 
ratio during cell-based luminescence measurements. Short-lived background fluorescence 
of cellular components, so-called autofluorescence can be rejected by using a delay time 
during the luminescence detection.  This method is known as time-resolved luminescence 
detection which provides a platform for analyzing nanomolar to picomolar binding 
agents. 
These luminescent features make the lanthanide-based materials useful in in vivo 
and in vitro biomedical imaging.  For example, synthesis of silica coated LaVO4:Eu
3+
 
core shell nanoparticles have been reported using a high temperature method.  Water 
dispersible silica engineered LaVO4:Eu
3+
 core shell nanoparticles exhibited good 
biocompatibility with human lung epithelial H522 cells and PBMC cells. The 
nanoparticles emit red luminescence (614 nm) upon UV excitation at 273 nm.
8
  
Lanthanide chelator-doped nanoparticles have also been utilized for binding 
assays.  For example, polystyrene beads with a diameter of 107 nm containing Eu(III)–2-
thenoyl- trifluoroacetone complexes were coated with streptavidin.  This assay protocol 
provided high sensitivity with a 100-fold increase of luminescence over the conventional 
assay methods using Eu-labeled streptavidin.  However, polystyrene nanoparticles have 
limitations for their use in cell-based binding assays including the larger particle size, 
swelling, and leakage of the encapsulated Eu-chelator molecules through surface defects. 
A new class of lanthanide materials, so-called upconverting nano-phosphors 
(UNPs), has recently been developed for use in biomedicine.  These nanomaterials emit 
visible light upon near infrared excitation (NIR).  Current high temperature synthetic 
7 
 
methods produce nanomaterials with hydrophobic coatings.  Most of the biological 
applications require hydrophilic UNPs with high upconverting luminescence efficiency.  
To this end, poly(vinylpyrrolidone) coated Gd/Yb/Er co-doped NaYF4 nanocrystals have 
been prepared with diameters of 40-100 nm using a one-pot solvothermal synthesis 
method.
9
  According to the literature reports, these nanoparticles exhibit the most 
efficient upconverting luminescence at 546 and 668 nm (upon excitation at 980 nm).
9
  
Another class of nanomaterials exhibits NIR-to-NIR (near infrared) upconversion process 
which provides deeper light penetration into a biological specimen and results in high 
contrast optical imaging due to the absence of an autofluorescence background and 
minimum light scattering upon NIR excitation.  Water-dispersible fluoride (NaYF4) 
nanocrystals (with a particle diameter of 20-30 nm) co-doped with Tm
3+
 and Yb
3+
 ions 
were used for NIR-based imaging.
10 
 In vitro cellular uptake of this class of nanoparticles 
was visualized using the characteristic emission of Tm
3+
 at 800 nm excited with 975 nm.  
NaYF4 nanocrystals co-doped with Tm
3+
 and Yb
3+
 ions were intravenously injected into 
mice with no observed cytotoxicity.  These nanoparticles demonstrated high contrast in 
vivo imaging in mice using upconversion photoluminescence.
10
   
 
           Notwithstanding the current progress using lanthanide-based nanomaterials in 
biotechnology, luminescence generation is very difficult by direct excitation of the 
lanthanide ions due to their poor ability to absorb light.  This weak light absorption is 
caused by the parity (Laporte) forbidden nature of the 4f electronic transitions resulting in 
very weak luminescence.
11
  In addition, poor water solubility and poor cell-selective 
targeting limit their use in biomedical applications. Most of the literature-reported 
8 
 
lanthanide nanoparticles are hydrophobic and face great challenges in effective imaging 
of cancer cells and tissues.  This project is designed to address the above three problems, 
especially the low luminescence efficiencies of lanthanide-based nanoparticles. 
 
1.2 INTRODUCTION TO RESEARCH 
 This research project was designed to address the limitations discussed in the 
background section.  We have designed synthetic methods to develop nanomaterials with 
improved photoluminescence and water-dispersibility.  The work is focused on two main 
different types of lanthanide-based nanoparticles: 
(a) europium-based down-converting nanoparticles  
i) LaEuF3: synthesized using low temperature method 
ii) Eu:NaYF4: synthesized using high temperature method 
Europium-based nanoparticles will be developed to improve the luminescence 
characteristics, hydrophilicity of the nanoparticle surface, and the selectivity of 
nanoparticles to melanoma cancer cell-surface receptors. 
 
(b) ytterbium-, and erbium-based (Yb:Er: NaYF4) upconverting nanoparticles.  
Yb:Er:NaYF4 upconverting nanoparticles will be designed to improve the 
hydrophilicity of the nanoparticle surface and the selectivity of nanoparticles to 
melanoma cancer cell-surface receptors. 
 
 
9 
 
1.2.1 Upconverting Nanoparticles  
Upconversion refers to the process where excitation is carried out with low energy 
photons [usually near-infrared (NIR)] resulting in the emission of high energy photons 
(visible).
12
 This phenomena is made possible in lanthanides due to multiple metastable 
electronic states.  Upconverting lanthanide nanoparticles consist of two components, an 
inorganic host lattice and dopant ions that are capable of upconverting.  The transparent 
crystalline host lattice is chosen to be NaYF4 which can accommodate trivalent 
lanthanide ions with multiple metastable excited states.  Ytterbium (Yb
3+
) has a high 
absorption coefficiency (in the NIR region) that can increase upconversion efficiency.  In 
the upconversion system Yb
3+
 acts as the absorber, taking the lower energy photons from 
the excitation source, and energy will be transferred to erbium (Er
3+
) which acts as the 
emitter.  Er
3+
 emits high energy photons (in the visible region) as shown in Figure 1.2.
12  
 
                       
Figure 1.2. Upconversion mechanism in the Yb
3+
 and Er
3+
 doped NaYF4 nanoparticle 
system.
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 Many literature reported upconverting nanoparticles exhibit a sharp emission 
bandwidth, long luminescence lifetime, high photostability, and low cytotoxicity,
 
which 
render them particularly useful in bio-medical imaging applications.
13
 Upconverting 
nanoparticles are typically prepared in the presence of a hydrophobic capping ligand 
(such as oleic acid) that controls the particle growth and stabilizes the particles against 
aggregation in solution.
14
  In this project we optimized a synthetic method to replace the 
hydrophobic capping ligands on the surface with a hydrophilic ligand using a ligand 
exchange reaction.  The ligand exchange method can be used with a wide variety of 
hydrophilic organic molecules such as aminoethyl phosphate (AEP) (Figure 1.3).
15,16
  
Water soluble AEP coated NaYF4: Yb
3+
, Er
3+ 
nanoparticles can efficiently be dispersed in 
biological media for imaging applications. 
 
O
O
-
O
-
O
P
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Figure 1.3. Structure of aminoethyl phosphate. 
 
1.2.2 Europium-based Down-converting Lanthanide Nanoparticles 
Europium-based nanoparticles can be utilized for biomedical imaging through 
their energy down-conversion process.  In down-conversion process the excitation is 
carried out using high-energy photons resulting in an emission of low-energy photons 
(Figure 1.4).
17
  
11 
 
 
 
 
 
 
Figure 1.4. Energy down-conversion process. 
 
Among different lanthanide metals, europium shows red emission in a nanocrystal 
with an emission wavelength of 615 nm (
5
D0        
7
F2 electronic transition) as shown in 
Figure 1.5.
17,18
  Several research groups designed Eu-based nanoparticles that are suitable 
of cellular imaging.  For example, Eu2O3 (europium oxide),
19
 EuF3 (europium fluoride),
19
 
and EuPO4 (europium phosphate)
19 
 nanoparticles have been developed with red emission 
characteristics.  It has also been demonstrated that the nanoparticles can be attached to 
protein molecules for studying protein-protein interactions.
19
   
            The main drawback of europium-based down-converting lanthanide nanoparticles 
is the weak absorption of light.  We believe that the poor light absorption can be 
overcome by using a surface-coated chromophore ligand.  A chromophore ligand with 
efficient light absorption properties can be attached to the surface of the lanthanide-based 
nanoparticles.  The chromophore acts as an “antenna” which absorbs light and transfers 
energy to lanthanide-based excited states for an efficient luminescence.  This process is 
known as “sensitization” of lanthanide metal ions by an organic molecule and is 
represented schematically in Figure 1.6A.
18
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                                                                   (A) 
Figure 1.6 (A). Schematic representation of the sensitization process.
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                  Figure 1.5. Electronic energy-level diagram of the europium ion (Eu
3+
). 
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(B) 
Figure 1.6 (B). Schematic representation of lanthanide-centered luminescence.
20,21
 
 
In Figure 1.6B, 
1
S and 
3
T are the ligand-based singlet and triplet states, which can 
decay by fluorescence (F) or phosphorescence (P) processes, respectively, or through 
non-radiative (NR) pathways.  ISC is inter-system crossing between the two states and 
energy transfer (ET) leads to population of the Ln(III)-based excited states (f*).  The 
excited state of the Ln(III) decays by radiative pathways [luminescence (L)] to produce 
lanthanide-centered luminescence.   BT is the back-energy transfer which may happen if 
the triplet state of the ligand and the excited states of the metal ions are close in energy.
20
  
Lanthanide-centered luminescence is efficient if the ligand-based singlet and triplet 
energies are matched with the lanthanide-based excited states.  The structural parameters 
also play a role in energy transfer as the distance between the antenna and the metal ion is 
crucial for an efficient energy transfer process.
21
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The sensitization process has been widely used in lanthanide chelators to improve 
the luminescence properties. For example, europium complexes featuring fluorinated β-
diketonate ligands such as thenoyltrifluoroacetone (TTA), 4,4,4-trifluor-1phenyl-1,3-
butanedione (btfac), nitrogen p,p’-disubstituted bipyridine (dmbipy), and dimethyl 
phenanthroline (dmphen) were synthesized.
22
  UV excitation of these complexes led to 
red luminescence characteristics of the Eu(III) ion.  These chelator compounds exhibit 
impressive quantum yield values (25% to 35%).  For example, Eu(TTA)3(dmbipy) 
(Figure 1.7) exhibited red luminescence with a quantum yield value of 23%.
23 
 
 
 
 
 
 
 
Figure 1.7. Molecular structure of Eu(TTA)3(dmphen). 
However, a sensitization phenomenon is currently not well developed for 
lanthanide-based nanoparticle systems.  Some sensitized lanthanide nanoparticles exhibit 
very low quantum yield values.  For example, LaEuF3-AEP (AEP = aminoethyl 
phosphate) nanoparticles were sensitized with the 6-carboxy-5’-methyl-2.2’-bipyridine 
(bipyCOO
-
) ligand (Figure 1.8).  These nanoparticles exhibited a luminescence quantum 
yield value of 2.8%.
11
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Figure 1.8. Structure of bipyCOO
-
 ligand. 
 
Hypothesis: We hypothesized that the sensitization of Eu-based nanoparticles with 
fluorinated oxygen-donor ligands will significantly enhance the luminescence properties 
of the nanoparticles suitable for in vitro cancer imaging with a high signal-to-noise ratio. 
In this project, we have chosen to use a class of organic ligands known as           
“β-diketonates” which are very efficient chromophores for the sensitization of 
europium(III) ions based on the above mentioned chelation chemistry.  We plan to 
improve the luminescence efficiency of the nanoparticles using β-diketonate ligands, 
namely 4,4,4-trifluoro-1-(2-thienyl)-1,3-butandione (TTA), 1,1,1,5,5,5-
hexafluoroacetylacetone (HFA), and 4,4,4-trifluoro-1-pheny-1,3-butanedione (btfa)
22,23
 
(Figure 1.9a,1.9b,1.9c) as the surface functionalization agents.  Initial Eu-doped LaF3 
(lanthanum fluoride) nanoparticles will be prepared using a low temperature method 
utilizing aminoethyl phosphate (AEP)  as the surface stabilization agent.
11
  In addition to
 
using the AEP ligand we plan to use other water soluble ligands including citric acid and 
mercaptopropionic acid (Figure 1.9d and 1.9e) to further explore different surface 
functionalizing ligands for improved water dispersibility of nanoparticles.
15
  The surface 
of these nanoparticles will then be functionalized with the TTA ligand for improved 
luminescence properties.   
16 
 
A schematic representation of the proposed ligand exchange protocol is depicted in 
Figure 1.10. 
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Figure 1.9. Structures of (a) 4,4,4-trifluoro-1-(2-thienyl)-1,3-butandione (TTA) (b) 
1,1,1,5,5,5-hexafluoroacetylacetone (HFA) (c) 4,4,4-trifluoro-1-pheny-1,3-butanedione 
(btfa) (d) citric acid and (e) mercaptopropionic acid. 
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Figure 1.10. Surface functionalization of AEP coated LaEuF3 nanoparticles with TTA 
chromophore.        
Eu(III)-doped NaYF4 nanoparticles will be prepared using a high temperature 
decomposition method using oleic acid (CH3(CH2)7CH=CH(CH2)7COOH) (Figure 1.11) 
as the stabilization agent.  Hydrophobic oleic acid can be removed using an acid 
treatment protocol
24 
and the TTA ligand can then be introduced to Eu:NaYF4 
nanoparticles system as shown in Figure 1.12. 
CH3
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Figure 1.11. Molecular structure of oleic acid. 
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Figure 1.12. Surface functionalization of Eu:NaYF4 nanoparticles with the TTA ligand. 
Both upconverting and europium-based down-converting nanoparticles will be 
labeled with melanocyte stimulating hormone (MSH4) peptide.  This can be done 
through the carboxylic-amino coupling between the peptide and the AEP ligand.  MSH4 
is a small peptide which contains four amino acid residues.  Those 4 amino acids are 
histidine (His), D-phenylalanine (D-Phe), arginine (Arg), and tryptophan (Trp) (Figure 
1.13).  MSH4 selectively binds to the human melanocortin receptor system which 
belongs to a type of G-protein coupled receptor (GPCR) family.  It has been recently 
reported that human melanocrotin-1 receptor (MC1R) is more abundant in melanoma 
cancer cells than those observed in normal melanoma cells.
25
  A linker based on 
polyethylene glycol (known as PEG-20) will be attached to the MSH4 hormone to 
minimize any binding interferences due to the presence of the nanoparticle.   
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MSH4-labeled nanoparticles can be utilized for selective imaging of melanoma cancer 
cells (Figure 1.14).  
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Figure 1.13. Structure of MSH4 peptide (His-D-Phe-Arg-Trp). 
 
Figure 1.14. Schematic representation of ligand receptor coupling between MC1R 
receptor and MSH4-labeled nanoparticles. 
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CHAPTER 2 
EXPERIMENTAL 
2.1 MATERIALS AND INSTRUMENTATION  
All the reagents were purchased from Aldrich or Fisher Scientific.  The reagents 
were used without further purification.  Nanopure water with a resistivity of 18.2MΩ was 
obtained from a Barnstead NANOpure Diamond system with a 0.2μm hollow fiber filter. 
2.1.1 Fourier Transform Infrared Spectroscopy 
Fourier transform infrared (FT-IR) spectra were collected using a Perkin-Elmer 
Spectrum One spectrometer.  Solid samples were vacuumed dried before mounting on the 
stage of the FT-IR instrument.  Spectra were collected using Spectrum One software at a 
resolution of 4 cm
-1
 with 16 scans averaged per spectrum in the range of 400 - 4000 cm
-1
.  
2.1.2 Absorption Spectroscopy 
Ultraviolet (UV) visible spectra were recorded on an Agilent 8453 UV-visible 
Spectrometer.  Samples were prepared by dispersing 0.1 mg of the nanoparticle samples 
in 2 mL of the solvent (water or water:ethanol (1:1 (v/v)).  Samples were sonicated for 15 
minutes at room temperature before collecting the spectra.  The absorption spectra were 
collected from 200 nm to 900 nm using quartz cuvettes. 
2.1.3 Luminescence Spectroscopy 
Luminescence spectra were collected using a Perkin Elmer LS-55 fluorescence 
spectrometer with a 5 nm slit width using quartz cuvettes.  Samples were prepared by 
21 
 
dispersing 0.1 mg of the nanoparticle samples in 2 mL of the solvent (water or 
water:ethanol 1:1 (v/v)).  The samples were sonicated for 15 minutes at room temperature 
before collecting spectra.  The samples were excited at 340 nm and the emission spectra 
were collected from 200 nm to 700 nm using a scan speed of 200 nm/minute. 
2.1.4 X-ray Powder Diffraction Studies 
Solid samples were grounded and mounted on the XRD well plate.  X-ray powder 
diffraction spectra were collected using a desktop X-ray diffractometer “MiniFlex
+
”, with 
a Cu-Kα (λ = 1.5418 A˚) radiation and a scan speed of 0.5° min
-1
.  Diffraction data were 
collected from 2θ = 3˚ to 2θ = 80˚.  The X-ray generator was set at a power of 30 kV with 
a current of 40 mA.  X-ray diffraction data were analyzed using Materials Data Jade 
7 software. 
2.1.5 Thermogravimetric Analysis 
Thermogravimetric analyses were conducted using a Perkin Elmer Diamond 
Differential Thermal Analyzer with 20 mL min-1 N2 purge.  Dry solid powders were 
used to collect spectra.  The temperature was set to ramp from 50 
°
C to 600 
°
C  at a 
temperature ramp of 5˚C min
-1
.  Onset option and X, Y tangents of the Pyris program 
were used to determine the mass loss points.  Delta Y option was used to calculate the 
mass percentages. 
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2.1.6 Transmission Electron Microscopy (TEM) & Scanning Electron Microscopy (SEM) 
Studies 
Size and the shape of the nanoparticles were determined using a TEM 9500 
microscope with an operating voltage of 300 kV and a STEM-Hitachi HD2000 
microscope operating at 200 kV.  Samples were prepared by making a dispersion of 
nanoparticles (1 mg nanoparticles / 1mL solvent) and drop casting 200 μL of the sample 
on a carbon coated copper grid (300 mesh).  Samples were dried at room temperature by 
natural solvent evaporation. 
2.1.7 Luminescence Lifetime Measurements 
Luminescence lifetime measurements of the nanoparticles were carried out using 
a photomultiplier tube (Hamamatsu R928) coupled to a 500 MHz band pass digital 
oscilloscope (Tektronix TDS 620B).  Excitation was provided by a tunable optical 
parametric oscillator (OPO) pumped by a Nd:YAG laser Q-switched at 20 Hz with a 3 ns 
pulse width. 
 
2.2 EUROPIUM BASED DOWN-CONVERTING NANOPARTICLES  
      (LOW TEMPERATURE METHOD) 
2.2.1 Preparation of LaEuF3-AEP Nanoparticles 
LaEuF3-AEP nanoparticles were synthesized using AEP, lanthanide (III) salts and 
sodium fluoride at pH 6.5 using a literature procedure
11
 with slight modifications.  
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Briefly, AEP (4 mmol, 675 mg) was dissolved in argon purged nanopure water (35 mL).  
The pH of the solution was adjusted to 6.5 by drop-wise addition of a 28% aqueous 
ammonia solution.  The reaction solution was heated to 75 °C while magnetic stirring.    
A mixture of LaCl3.7H2O (1.1 mmol, 444 mg) and Eu(NO3)3.5H2O (0.13 mmol, 56 mg) 
in methanol (2 mL) was added drop-wise to the AEP solution.  Then, NaF (3.1 mmol,      
130 mg) in water (2 mL) was added drop-wise to the stirring solution.  The clear reaction 
mixture was stirred for 2 hours at 75 °C with periodic argon purging (Figure 2.1).  
Ethanol (80 mL) was added to precipitate the nanoparticles (a white powder).  The 
nanoparticles were isolated by centrifugation (3000 rpm, 20 min), washed with ethanol 
(10 mL), and dried at room temperature.  
2.2.2 Preparation of LaEuF3-(AEP)-TTA Nanoparticles 
LaEuF3-AEP nanoparticles (75 mg) were dispersed in water (3 mL).  The solution 
of TTA (0.12 mmol, 16 mg) and triethylamine (0.14 mmol, 15 µL) in water (2 mL) was 
added drop-wise to the stirring reaction solution.  The solution was stirred for 2 hours at 
room temperature (Figure 2.2).  The product was isolated by centrifugation (3000 rpm,  
10 min).  A series of LaEuF3-(AEP)-TTA nanoparticles was prepared by changing the 
amount of TTA ligand (64 mg (0.48 mmol), 32 mg (0.24 mmol), 16 mg (0.12 mmol),      
8 mg (0.06 mmol), and 4 mg (0.03 mmol)). 
2.2.3 Preparation of LaEuF3-(AEP)-HFA Nanoparticles 
LaEuF3-(AEP)-HFA nanoparticles were prepared using 1,1,1,5,5,5-
hexafluoroacetylacetone (HFA) (0.096 mmol, 16 mg) and preparative procedures 
24 
 
identical to those used to synthesize LaEuF3-(AEP)-TTA nanoparticles.  The product was 
isolated by centrifugation (3000 rpm, 10 min).  
2.2.4 Preparation of LaEuF3-Mercaptopropionic Acid Nanoparticles 
LaEuF3-mercaptopropanoic acid nanoparticles were synthesized using 
mercaptopropionic acid (6.36 mmol, 675 mg), lanthanide (III) salts and sodium fluoride 
at pH 6.5 and preparative procedures identical to those used to synthesize LaEuF3-AEP 
nanoparticles. 
2.2.5 Preparation of LaEuF3-Citric Acid Nanoparticles 
LaEuF3-citric acid nanoparticles were synthesized using citric acid (9.5 mmol,     
2 g) and preparative procedures identical to those used to synthesize LaEuF3-AEP 
nanoparticles. 
2.2.6 Preparation of LaEuF3-(Citric Acid)-TTA Nanoparticles 
  LaEuF3-(citric acid)-TTA nanoparticles were prepared using LaEuF3-citric acid 
nanoparticles (75 mg), TTA (0.12 mmol, 16 mg) and preparative procedures identical to 
those used to synthesize LaEuF3-(AEP)-TTA nanoparticles. 
2.3 EUROPIUM BASED DOWN-CONVERTING NANOPARTICLES  
      (HIGH TEMPERATURE METHOD)  
2.3.1 Preparation of Oleic Acid Coated Eu:NaYF4 Nanoparticles 
Lanthanide trifluoroacetate precursors (Ln(TFA)3(H2O)2) (Figure 2.1) (Equation 
1) were prepared using europium oxide (Eu2O3), yttrium oxide (Y2O3) and trifluoroacetic 
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acid (99%).  Eu2O3 (10 mol %, 0.125 mmol, 43 mg) and Y2O3 (90 mol %, 1.125 mmol, 
250 mg) were dissolved in a solution mixture of trifluoroacetic acid (5 mL) and nanopure 
water (5 mL).  This reaction solution was refluxed at 80 °C.  The residual water and acid 
were then slowly evaporated to dryness at 50 °C.  Lanthanide trifluoroacetate precursors 
were isolated using a rotary evaporator.  
CF3COOH (aq) + Ln2O3 (s)           Ln(TFA)3(H2O)2 (s)         (1)       Ln = Eu
3+
, Y
3+
    
                                                   
Ln
O
O
CF3
O
O
F3C
O O
CF3
H2O H2O
 
Figure 2.1. Structure of a lanthanide trifluoroacetate precursor. 
 
Ln(TFA)3(H2O)2(s)  +  NaTFA(s) + oleic acid(aq) + octadecane(aq)          Eu:NaYF4(s)      (2) 
 Lanthanide TFA precursors and sodium TFA (NaTFA) (2.5 mmol, 340 mg) were 
added to the reaction vessel with oleic acid (90%, 20 mL) and octadecane (90%) (20 mL) 
(Equation 2).  The resulting solution was slowly heated to 100 °C under vacuum with 
magnetic stirring for 30 minutes to remove residual water and oxygen during which the 
flask was purged periodically with dry argon gas.  The resulting clear solution had a 
slight yellow color. The solution was then heated to 300 °C at an approximate rate of    
280 
0
C  
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10 °C/ min under dry argon and kept at this temperature for 1 hour. At approximately       
250 °C, the evolution of small gas bubbles was observed from the solution indicating the 
decomposition of the metal trifluoroacetate precursors.  A burst of nucleation was 
observed between 280-300 °C which resulted in the solution becoming turbid.  
Subsequently, the mixture was allowed to cool to room temperature during which time 
the solution became clear and a yellow colloidal suspension was obtained.  The 
nanocrystals were precipitated by the addition of hexane/acetone (v/v 1:4) and isolated 
via centrifugation (3000 rpm, 10 min).  The resulting nanoparticle pellet was washed 
once with ethanol (10 mL) and further purified by dispersing in a minimum amount of 
hexane and precipitating with excess ethanol.  The resulting pellet was subsequently 
washed with acetone and isolated via centrifugation (3000 rpm, 10 min).
24
  
2.3.2 Preparation of Oleic Acid Free Eu:NaYF4 Nanoparticles 
 Oleic acid coated Eu:NaYF4 nanoparticles (100 mg) were dispersed in nanopure 
water (10 mL).  The reaction was performed with stirring for 2 h while maintaining the 
pH at 4 by adding a solution of 0.1 M HCl.  During this reaction the carboxylate groups 
of the oleate ligand were protonated to yield oleic acid.  After the reaction was complete, 
the aqueous solution was mixed with diethyl ether to remove the oleic acid by liquid-
liquid extraction.  The extraction was carried out three times and the combined ether 
layers were re-extracted with water.  In addition, the water layers were combined and 
reextracted with diethyl ether.  The nanoparticles in the water dispersible fraction were 
recuperated by centrifugation (3000 rpm, 10 min) after precipitation with acetone.
24
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2.3.3 Preparation of TTA Coated Eu:NaYF4 Nanoparticles 
TTA coated Eu:NaYF4 nanoparticles were prepared using TTA (0.12 mmol,      
16 mg), oleic acid free Eu:NaYF4 nanoparticles (75 mg) and preparative procedures 
identical to those used to synthesize LaEuF3-(AEP)-TTA nanoparticles.  A series of TTA 
coated Eu:NaYF4 nanoparticles was prepared by using different amounts of TTA ligand 
(64 mg (0.48 mmol), 32 mg (0.24 mmol), 16 mg (0.12 mmol), 8 mg (0.06 mmol)). 
2.3.4 Preparation of btfa Coated Eu:NaYF4 Nanoparticles 
The btfa coated Eu:NaYF4 nanoparticles were prepared using btfa (0.11 mmol,          
16 mg), oleic acid free Eu:NaYF4 nanoparticles (75 mg) and preparative procedures 
identical to those used to synthesize LaEuF3-(AEP)-TTA nanoparticles.  
2.3.5 Preparation of Oleic Acid Free Eu:NaYF4-MSH4 Nanoparticles 
 Eu:NaYF4-MSH4 nanoparticles were prepared using MSH4 (0.15 mmol, 16 mg), 
oleic acid free Eu:NaYF4 nanoparticles (75 mg) and preparative procedures identical to 
those used to synthesize LaEuF3-(AEP)-TTA nanoparticles. 
2.3.6 Preparation of TTA Coated Eu:NaYF4-MSH4 Nanoparticles 
 TTA coated Eu:NaYF4-MSH4 nanoparticles were prepared using TTA           
(0.12 mmol, 16 mg), oleic acid free Eu:NaYF4-MSH4 nanoparticles (75 mg) and 
preparative procedures identical to those used to synthesize LaEuF3-(AEP)-TTA 
nanoparticles. 
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2.4 UPCONVERTING NANOPARTICLES  
2.4.1 Preparation of Oleic Acid Coated Yb:Er:NaYF4 Nanoparticles 
 Oleic acid coated Yb:Er:NaYF4 nanoparticles were prepared using Yb2O3      
(0.25 mmol, 98.5 mg), Er2O3 (0.025 mmol, 9.6 mg), Y2O3 (0.975 mmol, 220.2 mg) and 
preparative procedures identical to those used to synthesize oleic acid coated Eu:NaYF4 
nanoparticles.  
2.4.2 Preparation of Oleic Acid Free Yb:Er:NaYF4 Nanoparticles 
 Oleic acid free Yb:Er:NaYF4 nanoparticles were prepared using oleic acid coated 
Yb:Er:NaYF4 nanoparticles (100 mg) and preparative procedures identical to those used 
to synthesize oleic acid free Eu:NaYF4 nanoparticles.  
2.4.3 Preparation of AEP Coated Yb:Er:NaYF4 Nanoparticles 
 AEP coated Yb:Er:NaYF4 nanoparticles were prepared using AEP (0.11 mmol,   
16 mg), oleic acid free Yb:Er:NaYF4 nanoparticles (75 mg) and preparative procedures 
identical to those used to synthesize LaEuF3-(AEP)-TTA.  
2.5 MATERIALS CHARACTERIZATION  
Nanoparticles were characterized by UV-visible, infrared (FT-IR), and 
fluorescence spectroscopic techniques, transmission electron microscopy (TEM), 
scanning electron microscopy (SEM), thermogravimetric analysis (TGA), and X-ray 
powder diffraction (XRD).  Luminescence quantum yields (ɸ) of the nanoparticles were 
calculated using cresyl violet acetate as the reference (ɸR = 54 % in methanol)
23 
as shown 
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in Equation (3) where Abs, A and n denote the absorbance (at highest absorption 
maxima), integrated area of the emission spectrum, and the refractive index of the 
solvent, respectively. Subscripts R and S refer to the reference and the sample, 
respectively. 
23 
                 (AbsR) (As)  (n
2
S)                                          
 
Quantum yield measurements were carried out using three different 
concentrations of the nanoparticles.  Each measurement was repeated three times.  This 
procedure was repeated three times in three different days and the average quantum yield 
value was calculated using the 27 measurements.                                                   
Nanoparticle size was determined using a modified Sheerer equation and XRD 
data.  The Sheerer equation (Equation 4) was developed to calculate the nano-crystallite 
size (L) by XRD radiation of wavelength (λ) (Cu Kα = 0.154 nm) from measuring the full 
width at half maximum of peaks (β) in radians located at any 2θ in the XRD pattern.  The 
shape factor (K) can range from 0.62 to 2.08 and is usually taken to be about 0.89.  
However, if all of the peaks of a pattern are going to give a similar value of L, then βcosθ 
must be identical.  
          L =                     (4) 
In a plot of lnβ vs ln(1/cosθ), the intercept of a least squares regression is Kλ/L. 
This can be used to obtain the nanoparticle size, L.
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Nanoparticle size distribution was determined using a bitmap picture of the TEM 
image.  By calculating the number of pixels for each nanoparticle, the average particle 
diameter can be evaluated.  The area for the luminescence spectra was calculated using 
OriginLab data analysis and graphing software.  
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 CHAPTER 3 
RESULTS AND DISCUSSION 
 
Our research is planned to prepare three different types of lanthanide nanoparticles 
to address their limitations for biological applications.  The limitations include poor water 
dispersibility, poor luminescence characteristics, and selectivity.  This research project is 
focused on three different types of nanoparticles: 
I. LaEuF3 nanoparticles – low temperature method 
II. Eu-NaYF4 nanoparticles – high temperature method 
III. Yb-Er-NaYF4 upconverting nanoparticles 
 
3.1. TTA COATED LaEuF3-AEP NANOPARTICLES 
       (EUROPIUM-BASED DOWN-CONVERTING NANOPARTICLES:  
       LOW TEMPERATURE METHOD) 
Our results obtained for europium-based down-converting nanoparticles are 
discussed herein.  In our modified preparation, the AEP ligand in LaEuF3-AEP 
nanoparticles was exchanged with the TTA ligand in water to yield TTA coated LaEuF3-
(AEP)-TTA nanoparticles.  LaEuF3-AEP nanoparticles are readily dispersible in water.  
After treatment with TTA, a pink color precipitate was observed due to the hydrophobic 
nature of the surface-coated TTA ligand.  LaEuF3-(AEP)-TTA nanoparticles show bright 
red luminescence upon excitation using a portable UV lamp as opposed to faint emission 
Eu-based down-converting  
nanoparticles 
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observed from the LaEuF3-AEP nanoparticles.  The brightest luminescence was observed 
for the nanoparticles where 32 mg of TTA was used for the exchange reaction. 
3.1.1 Fourier Transform Infrared Studies 
FT-IR spectra of the free ligand TTA, LaEuF3-AEP, and LaEuF3-(AEP)-TTA 
nanoparticles were obtained for the dried powders as shown in Figure 3.1(A).  The FT-IR 
spectrum of LaEuF3-AEP nanoparticles has a characteristic peak for the phosphate group 
around 1080 cm
-1
.  The peak around 2900 cm
-1
 can be assigned to N-H stretching.  This 
confirms the presence of the surface coating AEP ligand.  We confirm a successful 
surface functionalization with TTA ligand by evaluating the carbonyl (C=O) stretching 
frequency of the TTA ligand.  The carbonyl (C=O) stretching frequency in LaEuF3-
(AEP)-TTA nanoparticles was shifted from 1640 cm
-1
 (Free TTA) to 1600 cm
-1
 (Figure 
3.1(B)). 
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Figure 3.1(A). FT-IR spectra of TTA, LaEuF3-AEP and LaEuF3-(AEP)-TTA 
nanoparticles. 
 
Figure 3.1(B). Fingerprint region of the FT-IR spectra of TTA, LaEuF3-AEP and 
LaEuF3-(AEP)-TTA nanoparticles. 
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3.1.2 UV-visible Absorption and Luminescence Studies 
            TTA attachment to the nanoparticle surface was further confirmed by UV-Vis 
absorption spectroscopy (Figure 3.2).  The change in the UV-visible spectrum from 
LaEuF3-AEP to LaEuF3-(AEP)-TTA nanoparticles is due to the absorption properties of 
the newly introduced TTA ligand providing a chromophore for efficient light absorption.  
A characteristic absorbance maximum at around 343 nm was evident after TTA exchange 
which matches a characteristic absorption peak in pure TTA ligand.  
 Figure 3.2 depicts the intense red luminescence of LaEuF3-(AEP)-TTA 
nanoparticles with an emission maximum at 614 nm due to the 
5
D0 to 
7
F2 electronic 
transition.  Collecting a luminescence spectrum of LaEuF3-AEP nanoparticles (before 
ligand exchange with TTA) was not successful due to its weak luminescence 
characteristics.  Relatively higher concentration of LaEuF3-AEP nanoparticles were 
required to obtain a luminescence spectrum.  This observation provides evidence for our 
proposed sensitization process resulting in improved luminescence upon TTA ligand 
exchange. 
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Figure 3.2. UV-visible absorption spectra of LaEuF3-AEP (dispersed in water) and 
LaEuF3-(AEP)-TTA nanoparticles (dispersed in a water / methanol solution) and 
luminescence spectrum of LaEuF3-(AEP)-TTA nanoparticles (excited at 343 nm). 
              
3.1.3 X-Ray Powder Diffraction Studies       
X-Ray powder diffraction (XRD) patterns of the nanoparticles are shown in 
Figure 3.3.  The XRD peaks observed at 2θ values of 24°, 27°, 43°, and 50.5° confirm the 
hexagonal structure of LaF3 nanoparticles.  The broad peaks indicate the low crystallinity 
of the nanoparticles due to the use of a relatively low temperature during the synthesis.  
Due to the low crystallinity and broader XRD peaks, Use of the Sheerer equation was not 
successful in determining the size of the EuLaF3 nanoparticles.  No significant change in 
the crystal structure of the nanoparticles was observed after the ligand exchange process 
according to Figure 3.3(A) and 3.3(B). 
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(A) 
 
(B) 
Figure 3.3. X-ray powder diffraction (XRD) pattern of (A) LaEuF3-AEP and (B) LaEuF3-
(AEP)-TTA nanoparticles. 
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3.1.4 Luminescent Lifetime Measurements       
According to Figure 3.4 LaEuF3-AEP nanoparticles show a luminescence lifetime 
of 900 µs whereas the lifetime of LaEuF3-(AEP)-TTA nanoparticles is 650 µs.  No 
significant change in the lifetimes was observed using direct excitation of Eu(III) ions 
(465 nm) and TTA excitation (350 nm).  LaEuF3-AEP nanoparticles showed a relatively 
higher luminescence lifetime than that of LaEuF3-(AEP)-TTA nanoparticles.  This may 
be due to the quenching of the luminescence due to a non-radiative decay process in the 
presence of the TTA ligands.  When compared with the luminescence lifetimes of organic 
dyes (observed in the ns time scale), the lanthanide nanoparticles have relatively higher 
lifetimes. A Long luminescence lifetime warrants sensitive imaging and cell-based 
binding assays with a standard 400 μs delay time.  
 
 
Figure 3.4. Lifetime measurements of LaEuF3-AEP and LaEuF3-(AEP)-TTA 
nanoparticles. 
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3.1.5 Transmission Electron Microscope (TEM) Studies     
TEM images of LaEuF3-(AEP)-TTA nanoparticles are shown in Figure 3.5.  The 
diameters of the spherical nanoparticles are found to be 100-150 nm.  The lattice fringes 
confirm the crystallanity of the nanoparticles with a lattice spacing of 3.117 Å.  The size 
of the nanoparticles may be too large for in vivo biological applications.  In this project 
we are considering melanoma skin cells with an approximate size of 30 µm.
27
 When we 
consider this cell size, these nanoparticles may penetrate through skin cells.  However, 
there may be difficulties in filtering the nanoparticles through the kidney cells due to their 
large size. 
      
 
Figure 3.5. Transmission electron microscope images of (a) LaEuF3-(AEP)-TTA 
nanoparticles (b) a single nanoparticle and (c) the lattice structure of the nanoparticles. 
 
 
 
 
 
(a) (b) (c) 
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3.1.6 Thermogravimetric Analysis 
TGA diagram of LaEuF3-AEP nanoparticles (Figure 3.6(A)) exhibited one mass 
loss at 218 °C.  This mass loss is assigned to the removal of AEP ligand.  TGA diagrams 
of LaEuF3-(AEP)-TTA nanoparticles (Figure 3.6(B), (C), (D), (E)) exhibit two mass 
losses.  The mass loss at 218 
°
C is consistence with the mass loss observed in the TGA 
diagram of LaEuF3-AEP (Figure 3.6(A)) nanoparticles.  This mass loss is assigned to the 
removal of AEP ligand.  According to these observations we confirm the presence of 
AEP ligand in all types of LaEuF3 nanoparticles.  In addition, another mass loss at       
155 °C, 137 °C, 127 °C and 124 
°
C was observed for LaEuF3-(AEP)-TTA nanoparticles 
using 8 mg, 16 mg, 32 mg, and 64 mg of TTA ligand, respectively.  This mass loss is 
assigned to the removal of TTA ligands.  Onset option and X, Y tangents of the TGA 
program were used to find the temperature range and the mass of the curve points.  The 
mass percentages of TTA ligand in different nanoparticles were calculated using delta Y 
and step options. 
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Figure 3.6. Thermogravimetric analysis of (A) LaEuF3-AEP and (B) LaEuF3-(AEP)-
TTA (8 mg) nanoparticles. 
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(C) 
 
(D) 
Figure 3.6. Thermogravimetric analysis of (C) LaEuF3-(AEP)-TTA (16 mg) and  
(D) LaEuF3-(AEP)-TTA (32 mg) nanoparticles. 
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(E)  
Figure 3.6. Thermogravimetric analysis of (E) LaEuF3-(AEP)-TTA (64 mg) 
nanoparticles. 
 
Table 3.1. (A). Mass percentages of TTA in LaEuF3-(AEP)-TTA nanoparticles (using 
delta Y option) 
Nanoparticles Mass percentage of 
TTA (%) 
Mass percentage of 
AEP (%) 
LaEuF3-(AEP)-TTA (8 mg) 13.72 20.30 
LaEuF3-(AEP)-TTA (16 mg) 17.52 19.63 
LaEuF3-(AEP)-TTA (32 mg) 38.05 11.73 
LaEuF3-(AEP)-TTA (64 mg) 41.38 12.80 
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Table 3.1 (B). Mass percentages of TTA in LaEuF3-(AEP)-TTA nanoparticles (using 
step option) 
Nanoparticles Mass percentage of 
 TTA (%) 
Mass percentage of  
AEP (%) 
LaEuF3-(AEP)-TTA (8 mg) 6.77 25.77 
LaEuF3-(AEP)-TTA (16 mg) 10.69 19.51 
LaEuF3-(AEP)-TTA (32 mg) 20.06 13.28 
LaEuF3-(AEP)-TTA (64 mg) 19.21 15.91 
 
According to Table 3.1(A) TTA percentage of LaEuF3-(AEP)-TTA nanoparticles 
varies with the TTA amount used in the synthesis.  The highest TTA percentages, 38% 
and 41% were observed for the nanoparticles where we used 32 mg and 64 mg of TTA 
ligand, respectively.  We can assume that the highest TTA coverage of LaEuF3-(AEP)-
TTA nanoparticles is within 38% and 41%.  LaEuF3-(AEP)-TTA (32 mg) and LaEuF3-
(AEP)-TTA (64 mg) nanoparticles exhibit the highest observed luminescence quantum 
yield.  These results are consistence with the observed TTA percentages.  AEP 
percentage was decreased when we increase the TTA amount. The lowest AEP mass 
percentage was observed for LaEuF3-(AEP)-TTA (32 mg) nanoparticles.  Based on these 
observations we confirm the ligand exchange process between TTA and AEP. 
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3.1.7 Luminescence Quantum Yields 
Luminescence quantum yields provide a quantitative comparison of the observed 
luminescence among the various surface functionalized nanoparticles.  Table 3.2 shows 
the calculated relative quantum yields of the nanoparticles studied in this project.  
LaEuF3-AEP nanoparticles show a very low luminescence quantum yield of 0.0009 %.  
As was predicted, an impressive enhancement of luminescence quantum yield was 
observed for the TTA exchanged nanoparticles.  The highest quantum yield of 4.0 % was 
observed for the nanoparticles after using 32 mg of TTA ligand for the exchange process.  
This value is 1,000 times higher than the LaEuF3-AEP nanoparticles (before the 
exchange process).  The standard deviation of the luminescence quantum yield values 
was calculated using Microsoft Excel software.  Luminescence intensity is directly 
proportional to the amount of TTA used during the synthesis.  Improved luminescence 
intensities were evident at all levels of TTA exchange compared to the luminescence 
observed for the LaEuF3-AEP nanoparticles.  Figure 3.7 illustrates the luminescence 
enhancement of the nanoparticles upon TTA coating. 
 
 
 
Figure 3.7. Photoluminescence of TTA-uncoated (left) and TTA-coated LaEuF3-AEP 
nanoparticles (right) (The nanoparticles were excited using a portable UV lamp at        
365 nm). 
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Table 3.2. Luminescence quantum yield values of the prepared LaEuF3-(AEP)-TTA 
nanoparticles.  
 
Nanoparticles ɸ Standard 
Deviation 
  LaEuF3-AEP 0.0009% 0.000012 
LaEuF3-(AEP)-TTA (4 mg) 0.3% 0.093 
LaEuF3-(AEP)-TTA (8 mg) 0.4% 0.082 
LaEuF3-(AEP)-TTA (16 mg) 1.0% 0.102 
LaEuF3-(AEP)-TTA (32 mg) 4.0% 0.091 
LaEuF3-(AEP)-TTA (64 mg) 3.9% 0.124 
 
3.2 TTA COATED LaEuF3-Citric Acid NANOPARTICLES 
      (EUROPIUM-BASED DOWN-CONVERTING NANOPARTICLES: 
      LOW TEMPERATURE METHOD) 
Citric acid is another type of water soluble ligand which can be used as a surface 
coating ligand for lanthanide nanoparticles. Citric acid coated LaEuF3 nanoparticles were 
reacted with TTA chromophore to produce TTA-coated nanoparticles. 
3.2.1 UV-visible Absorption and Luminescence Studies 
The UV-visible spectrum of LaEuF3-(Citric acid)-TTA nanoparticles (Figure 
3.8(A)) shows a characteristic peak at 343 nm which corresponds to the TTA ligand 
absorption. The luminescence spectrum of LaEuF3-(Citric acid)-TTA (Figure 3.8(B)) 
exhibited the characteristic peak of Eu(III) ions at 614 nm. 
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(A) 
 
(B) 
Figure 3.8. (A) UV-visible absorption spectrum and (B) luminescence spectrum (excited 
at 343 nm) of LaEuF3-(Citric)-TTA nanoparticles (dispersed in a water / methanol 
solution). 
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The quantum yield values of LaEuF3-(Citric)-TTA (16 mg) and LaEuF3-(Citric)-
TTA (32 mg)   nanoparticles are 1.7% and 1.9% respectively.  The calculated relative 
quantum yield of LaEuF3-(Citric)-TTA (32 mg) (1.9%) nanoparticles was lower than that 
observed for LaEuF3-(AEP)-TTA (32 mg) (4%) nanoparticles.  We assumed that AEP 
ligands can easily be removed from the nanoparticle surface during the ligand exchange 
process compared to the removal of citric acid ligands.  Citric acid ligand may be tightly 
bound to the nanoparticle surface via the carboxylic groups.  Therefore more TTA 
ligands can be exchanged with AEP ligands than with the citric acid ligands.  This results 
a higher quantum yield value of 4 % for the LaEuF3-(AEP)-TTA nanoparticles. 
3.2.2 X-Ray Powder Diffraction Studies     
The same peak positions of XRD pattern of LaEuF3-(AEP)-TTA (Figure 3.3(B)) 
were observed for LaEuF3-(Citric)-TTA nanoparticles (Figure 3.9) as well.  XRD pattern 
of LaEuF3-(Citric)-TTA confirmed the same crystal structure (hexagonal) of LaF3 which 
was observed for LaEuF3-AEP nanoparticles.  
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Figure 3.9. XRD spectrum of LaEuF3-(Citric acid)-TTA nanoparticles. 
3.3 LaEuF3-(AEP)-HFA NANOPARTICLES 
      (EUROPIUM-BASED DOWN-CONVERTING NANOPARTICLES: 
      LOW TEMPERATURE METHOD) 
 We explored another fluorinated ligand as a surface coating ligand.  A hexafluoro 
β-diketonate ligand, 1,1,1,5,5,5-hexatrifluoroacetylacetone (HFA) was tested as our 
sensitization ligand with the LaEuF3 nanoparticle system. 
3.3.1 UV-visible Absorption and Luminescence Studies 
 HFA-coated LaEuF3-AEP nanoparticles showed an absorption peak at 305 nm.  
This peak is observed in the free HFA ligand confirming the HFA attachment (Figure 
3.10A).  The luminescence peak was observed at 614 nm.  The observed luminescence 
was not bright compared to that observed for TTA coated nanoparticles.  The quantum 
yields of LaEuF3-(AEP)-HFA (16 mg) and LaEuF3-(AEP)-HFA (32 mg)   nanoparticles 
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are 0.29% and 0.78% respectvily.  The relative quantum yield was lower for the LaEuF3-
(AEP)-HFA (32 mg) (0.78%) nanoparticles than that observed for LaEuF3-(AEP)-TTA 
(32 mg) (4%) nanoparticles.  The excited energy of the ligands (HFA and TTA) should 
match with the 
5
D0 energy level of the Eu(III) ions.  The triplet energy of the HFA ligand 
may not match with the 
5
D0 energy level of the Eu(III) ions resulting a poor HFA ligand-
to-metal energy transfer. This may be a reason for the observed low quantum yield of 
LaEuF3-(AEP)-HFA nanoparticles.  
 
 
(A) 
Figure 3.10. (A) UV-visible absorption spectrum of LaEuF3-(AEP)-HFA (dispersed in a 
water / methanol solution)  
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(B) 
Figure 3.10. (B) Luminescence spectrum of LaEuF3-(AEP)-HFA (excited at 305 nm). 
 
3.3.2 X-Ray Powder Diffraction Studies       
The XRD spectrum of LaEuF3-(AEP)-HFA nanoparticles (Figure 3.11) confirms 
the hexagonal crystal structure observed for LaF3 with peaks around 2θ positions of 27˚, 
43˚, and 51˚. 
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Figure 3.11. XRD spectrum of LaEuF3-(AEP)-HFA nanoparticles. 
 
 
3.4 LaEuF3-MERCAPTOPROPIONIC ACID NANOPARTICLES  
     (EUROPIUM-BASED DOWN-CONVERTING NANOPARTICLES: 
     LOW TEMPERATURE METHOD)      
Mercaptopropionic acid was used as another water soluble ligand instead of AEP.  
Use of mercaptopropionic acid as a surfactant was unsuccessful considering the poor 
water solubility of resulting nanoparticles.  After the synthesis, a white colored, turbid 
solution was observed. 
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3.5 TTA COATED Eu:NaYF4 NANOPARTICLES 
      (HIGH TEMPERATURE METHOD) 
 LaEuF3-AEP nanoparticles exhibit relatively low luminescence quantum yields 
with a large particle size.  These particles, with an average diameter of 150 nm, may be 
used for in-vitro cell binding assays rather than in-vivo cell imaging.  In order to prepare 
smaller nanoparticles, a high temperature method was utilized.  Oleic acid coated  
Eu(III)-doped NaYF4 nanoparticles were synthesized successfully using a high 
temperature decomposition method.  This method involves dissolving lanthanide 
trifluoroacetate precursors in a high-boiling organic solvent (octadecane) with the assistance 
of a surfactant (oleic acid).  Oleic acid is a very effective surfactant for producing small 
size nanoparticles.
28
 The growth mechanism of nanocrystals has been systematically 
investigated, and it has been shown that the trifluoroacetate precursors in hot surfactant 
solutions go through a unique delayed nucleation pathway.  This thermal decomposition 
method is effective and convenient for the preparation of the pure hexagonal (β) phase of 
NaYF4 with morphologies and architectures including plates, spheres and ellipses 
controlled by varying the oleic acid surfactant concentration.
29,30
  Even though this 
method was used to prepare small size nanoparticles, the hydrophobic nature of the oleic 
acid and the low luminescence efficiency are main drawbacks.  We have developed a 
modified synthetic method to remove the hydrophobic oleic acid from the nanoparticle 
surface.  This approach is based on an acid treatment protocol.  At pH 4, oleic acid can be 
protonated and detached from the lanthanide nanoparticles.  Oleic acid free nanoparticles 
were suspended in water and coated with the chromophore (TTA).  Characterization of 
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oleic acid coated, oleic acid free and TTA coated Eu:NaYF4 nanoparticles are discussed 
in this section.  
3.5.1 Fourier Transform Infrared Studies 
FT-IR spectra were obtained for solid nanoparticles as shown in Figure 3.12.  The 
vibrational band in the FT-IR spectrum of oleic acid (Figure 3.12(A)) at 1703 cm
-1 
corresponds to the stretching vibration of the carbonyl group (C=O) in oleic acid.  This 
vibrational band is absent in the oleic acid coated Eu:NaYF4 nanoparticles (Figure 
3.12(A)) and oleic acid free Eu:NaYF4 nanoparticles (Figure 3.12(B)).  Oleic acid 
molecules may be chemically adsorbed on the nanoparticle surface through coordination 
between the carboxylate group (COO
-
) and the unsaturated lanthanide ions on the surface 
(Figure 3.13).  The two peaks in the FT-IR spectrum of oleic acid coated Eu:NaYF4 
nanoparticles at 1564 cm
-1
 and 1465 cm
-1
 are due to the asymmetric and symmetric 
carboxylate group (COO
-
) stretches, respectively.  Oleic acid free nanoparticles maybe 
coated with surrounding water molecules.  FT-IR spectrum of oleic acid free Eu:NaYF4 
nanoparticles shows peaks at 1653 cm
-1
 and 3358 cm
-1
  due to OH bending and stretching 
of water, respectively (Figure 3.12(B)).  FT-IR spectrum of TTA coated Eu:NaYF4 
nanoparticles exhibits a characteristic peak around 1634 cm
-1
 due to the TTA attachment.  
The C=O stretching frequency in TTA coated Eu:NaYF4 nanoparticles was shifted from 
1640 cm
-1
 (Free TTA) (Figure 1.1(B) in Chapter 3, Section 3.1) to 1634 cm
-1
. 
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(A) 
 
(B) 
Figure 3.12. (A) FT-IR spectra of oleic acid and oleic acid coated Eu:NaYF4 
nanoparticles and (B) oleic acid free Eu:NaYF4 nanoparticles. 
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(C) 
Figure 3.12. (C) FT-IR spectrum of TTA coated Eu:NaYF4 nanoparticles. 
 
 
 
  
  
 
 
Figure 3.13. Schematic representation of the coordination of oleate in oleic acid coated 
Eu:NaYF4 nanoparticles.  
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3.5.2 UV-visible Absorption and Luminescence Studies 
 Oleic acid coated Eu:NaYF4 nanoparticles show a characteristic peak of oleic acid 
at 274 nm (Figure 3.14(A)).  When oleic acid was removed from the nanoparticles, this 
characteristic peak was disappeared due to the absence of oleic acid.  TTA coated 
Eu:NaYF4 nanoparticles have a characteristic peak at 343 nm due to the TTA 
chromophore which was illustrated in Figure 3.2(A) (Chapter 3, Section 3.1). 
  Figure 3.14(B) illustrates the luminescence spectra of TTA coated Eu:NaYF4 
upon 343 nm excitation.  The red fluorescence which is characteristic for Eu(III) (614 
nm) was enhanced when 32 mg of TTA was used to coat the nanoparticles compared to 
when 16 mg of TTA was used.  The quantum yields for TTA coated Eu:NaYF4 
nanoparticles are reported in Table 3.3.  The highest quantum yield of 17 % was observed 
after using 32 mg of TTA ligand for the exchange process.  This is a great enhancement 
in quantum yield when compared with LaEuF3-(AEP)-TTA nanoparticles which have a 
quantum yield of 4% when an equivalent amount of TTA was used.  
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(A) 
 
(B) 
Figure 3.14. (A) UV-visible absorption spectra of oleic acid (dispersed in 
dichloromethane), oleic acid coated Eu:NaYF4 (dispersed in dichloromethane), oleic acid 
free Eu:NaYF4 (dispersed in water) and TTA coated Eu:NaYF4 nanoparticles (dispersed 
in a methanol/water solution). (B) luminescence spectra of TTA coated Eu:NaYF4 
nanoparticles excited at 343 nm.  
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Table 3.3. Relative luminescence quantum yield values of the TTA coated Eu:NaYF4 
nanoparticles.  
Nanoparticles ɸ Standard 
Deviation 
Eu:NaYF4-TTA (8 mg) 0% 0 
Eu:NaYF4-TTA (16 mg) 3.9% 0.892 
Eu:NaYF4-TTA (32 mg) 17.0% 1.023 
Eu:NaYF4-TTA (64 mg) 7.2% 0.978 
 
3.5.3 X-Ray Powder Diffraction Studies   
Oleic acid coated Eu:NaYF4 nanoparticles exhibit a hexagonal crystal structure 
(Figure 3.15(A)).  The peaks around 27˚, 32˚, 47˚ and 54˚ 2θ positions represent the 
(111), (200), (220) and (311) planes, respectively.  Surface functionalization of 
Eu:NaYF4 nanoparticles did not change the hexagonal crystal structure.  After coating 
with TTA ligand, Eu:NaYF4 nanoparticles show the same peaks in the XRD spectrum 
(Figure 3.15(C)).  Oleic acid free Eu:NaYF4 nanoparticles exhibited sharp peaks due to 
higher crystallinity (Figure 3.15(B)).    
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(A) 
 
(B) 
Figure 3.15. XRD spectra of (A) oleic acid coated Eu:NaYF4 and (B) oleic acid free 
Eu:NaYF4 nanoparticles.  
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(C)  
 
                      
(D) 
Figure 3.15. XRD spectra of (C) TTA coated Eu:NaYF4 nanoparticles and (D) the 
reference spectrum for NaYF4 hexagonal crystal structure (JCPDS NO. 27-0699).
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3.5.4 Luminescence Lifetime Studies       
Luminescence lifetime measurements of Eu:NaYF4 nanoparticles were carried out 
using 355 nm excitation wavelength.  TTA coated Eu:NaYF4 nanoparticles and oleic acid 
free Eu:NaYF4 nanoparticles exhibit lifetimes of 1.8 ms and 1.7 ms, respectively (Figure 
3.16).  Eu:NaYF4 nanoparticles exhibited higher lifetime than LaEuF3 (650 µs and       
900 µs) nanoparticles.  This observation may be due to high crystallinity of the NaYF4 
nanoparticles than LaF3 nanoparticles.  High crystallinity favors low crystal defects 
resulting a longer luminescence lifetime with less luminescence quenching.  Thus 
Eu:NaYF4 nanoparticles have higher luminescence lifetime than that of LaEuF3 
nanoparticles.  Lanthanide nanoparticles exhibit a longer lifetime than those observed for 
organic dyes.  Rhodamine 6G and cy5 are some examples for organic dyes which are 
used for bio-medical imaging.  Luminescence life times of Rhodamine 6G and cy5 are 
4.08 ns and 1 ns, respectively.
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Figure 3.16.  Luminescence lifetime measurements of Eu:NaYF4 nanoparticles.  
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3.5.5 Transmission Electron Microscope (TEM) and Scanning Electron Microscope 
(SEM) Studies  
 
 According to TEM and SEM images, TTA coated Eu:NaYF4 nanoparticles have 
an average particle diameter of 15 nm.  This observed particle size is suitable for in vitro 
and in vivo cellular imaging which is an improvement when compared with LaEuF3-
(AEP)-TTA nanoparticles (150 nm) which were only suitable for in vitro studies.  
According to the modified Sheerer equation (Equation 4), the average diameter of the 
nanoparticles is 19 nm.  Particle size distribution was calculated based on the TEM image 
as shown in Figure 3.18.  Forty three percentages of the nanoparticles have a diameter of 
21 nm. 
 
 
Figure 3.17. (A) TEM image (B) lattice structure (C) SEM image of Eu:NaYF4-TTA 
nanoparticles. 
 
A B C 
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Figure 3.18. Particles size distribution of Eu:NaYF4-TTA nanoparticles calculated from 
the TEM image. 
 
 
3.5.6 Energy Dispersive X-Ray Mapping Studies (EDS) 
EDS can be used to find the chemical composition of materials down to a spot 
size of a few microns, and to create elemental composition maps.
33 
 The EDS elemental 
map (Figure 3.19) endorses the elemental composition of oleic acid free Eu:NaYF4 
nanoparticles.  Na, Y, Eu and F elements are present in Eu:NaYF4-oleic acid free 
nanoparticles as shown in the EDS spectrum in Figure 3.20.  
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Figure 3.19. EDS elemental maps and SEM image of oleic acid free Eu:NaYF4 
nanoparticles (Y=green, Eu = blue, Na = purple).  
 
 
Figure 3.20. EDS spectrum of oleic acid free Eu:NaYF4 nanoparticles. 
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3.5.7 Thermogravimetric Analysis (TGA) 
The TGA diagram of oleic acid coated Eu:NaYF4 nanoparticles shows mass 
losses around 147 ˚C, 292 ˚C and 398 ˚C (Figure 3.21(A)).  The mass losses around     
147 ˚C and 292 ˚C may be due to the removal of oleic acid.  Those mass losses didn’t 
appear in oleic acid free Eu:NaYF4 nanoparticles due to the lack of oleic acid (Figure 
3.21 (B)).  The mass loss observed at 375 ˚C in oleic acid free Eu:NaYF4 nanoparticles 
(Figure 3.21(B)) can be observed in the same temperature range in all Eu:NaYF4 
nanoparticles.    This weight loss is the same for all three types of nanoparticle systems. 
We believe that this may be due to the decomposition of trifluoroacetate precursors that 
might have been adsorbed or trapped in the nanocrystals.  Based on our mass assignments 
the mass percent of oleic acid in oleic acid coated Eu:NaYF4 nanoparticles is 13.26%. 
  
(A) 
Figure 3.21. TGA diagram of (A) oleic acid coated Eu:NaYF4 nanoparticles.  
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(B) 
 
(C) 
Figure 3.21. TGA diagrams of (B) oleic acid-free and (C) Eu:NaYF4-TTA(8 mg) 
nanoparticles.  
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(D) 
 
(E)  
Figure 3.21. TGA diagrams of (D) Eu:NaYF4-TTA(16 mg) and (E) Eu:NaYF4-TTA    
(32 mg) nanoparticles. 
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(F) 
Figure 3.21. TGA diagrams of (F) Eu:NaYF4-TTA(64 mg) nanoparticles.  
 
The TGA diagram of 8 mg of TTA coated Eu:NaYF4 nanoparticles did not exhibit 
clear weight losses (Figure 3.21(C)).  The TTA mass percentage was 0.18%.  This is low 
when compared with the TTA percentages observed for other nanoparticles (Table 3.4).  
Extremely low TTA percentage may be the reason that we were unable to measure the 
luminescence quantum yield of TTA(8mg)-coated Eu:NaYF4 nanoparticles.  The TGA 
diagram of 16 mg of TTA coated Eu:NaYF4 nanoparticles shows weight losses at 162 ˚C, 
317 ˚C and 405 ˚C (Figure 3.21(D)).  TGA diagram of 32 mg of TTA coated Eu:NaYF4 
nanoparticles shows weight losses at 104 ˚C, 171 ˚C, 306 ˚C and 392 ˚C (Figure 3.21(E)).  
The weight loss around 104 ˚C may be due to the detachment of loosely bound water 
molecules.  TGA diagram of 64 mg of TTA coated Eu:NaYF4 nanoparticles also shows 
similar weight losses.  We assume that the weight loss around 171 ˚C, 174 °C and 162 ˚C 
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may be due to the removal of TTA ligand.  TTA percentages of nanoparticles were 
calculated using delta Y and step options (Table 3.4).  The highest TTA mass percentage 
(12.53%) was observed for Eu:NaYF4-TTA(32 mg) nanoparticles.  Highest quantum 
yield was observed for the same nanoparticle system.  This confirms that the highest TTA 
amount on the nanoparticle surface will give the highest quantum yield.  When we 
compared with oleic acid mass percentage in oleic acid coated Eu:NaYF4 nanoparticles, 
13% may be the highest saturated surface coverage for Eu:NaYF4 nanoparticle system. 
 
Table 3.4. TTA mass percentages of Eu:NaYF4-TTA nanoparticles (using the step 
option) 
 
Nanoparticles Mass percentage of TTA (%) 
Eu:NaYF4-TTA (16 mg) 0.18 
Eu:NaYF4-TTA (16 mg) 7.69 
Eu:NaYF4-TTA (32 mg) 12.53 
Eu:NaYF4-TTA (64 mg) 9.73 
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3.6 btfa COATED Eu:NaYF4 NANOPARTICLES 
(HIGH TEMPERATURE METHOD) 
Oleic acid free Eu:NaYF4 nanoparticles were surface functionalized with another 
β-diketone (chromophore), namely 4,4,4-trifluoro-1-pheny-1,3-butanedione (btfa).  32 
mg and 16 mg of btfa ligand were used for the surface functionalization of oleic acid free 
Eu:NaYF4 nanoparticles (75 mg) using a similar ligand exchange process used for TTA 
coating (Chapter, Section 2.2.2).  The quantum yield was calculated for btfa coated 
Eu:NaYF4 nano- particles using cresyl violet acetate as the standard.  Observed quantum 
yield values were 4.2% and 4.0% for 32mg and 16 mg of btfa coated Eu:NaYF4 
nanoparticles, respectively.  When compared with TTA ligand, we confirm that btfa was 
not an efficient sensitizer ligand for the Eu:NaYF4 nanoparticles.  
 
3.6.1 UV-visible Absorption and Luminescence Studies 
UV-visible absorption spectrum of the btfa ligand (Figure 3.22(A)) exhibited a 
peak at 324 nm.  btfa coated Eu:NaYF4 nanoparticles have the same characteristic peak at 
324 nm confirming the presence of the btfa ligand in Eu:NaYF4 nanoparticles.  The 
luminescence spectrum upon 324 nm excitation (Figure 3.22(B)) displayed a peak at   
614 nm which is unique to Eu(III) ions.  
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(A) 
 
(B) 
Figure 3.22. (A) UV-visible absorption spectrum and (B) luminescence studies of btfa 
coated Eu:NaYF4 nanoparticles (dispersed in a water/ methanol solution).  
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3.7 TTA COATED Eu:NaYF4-MSH4 NANOPARTICLES 
(HIGH TEMPERATURE METHOD) 
The ultimate goal of this project is to attach the MSH4 (melanocyte stimulating 
hormone) peptide ligand to the nanoparticle surface for potential imaging of melanoma 
cancer cells.  Oleic acid free Eu:NaYF4 nanoparticles were surface functionalized with 
MSH4 hormone, and afterward these nanoparticles were coated with TTA ligand.  
 
3.7.1 Fourier Transform Infrared Studies 
FT-IR spectra were collected for solid particles of MSH4 and Eu:NaYF4-MSH4 
nanoparticles as shown in Figure 3.23.  The IR spectrum of Eu:NaYF4-MSH4 
nanoparticles exhibited some characteristic peaks due to MSH4 hormone as shown in 
Figure 3.23(A) and (B).  The peaks at 1653 cm
-1
, 2990 cm
-1
 and 3338 cm
-1 
were common 
for both IR spectra of MSH4 and Eu:NaYF4-MSH4 although the latter two are red shifted 
by 45 cm
-1 
and 10 cm
-1
 respectively in the nanoparticles spectrum.  The IR spectrum of 
TTA coated Eu:NaYF4-MSH4 (Figure 3.23(C)) exhibits the peak around 1643 cm
-1
 due 
to TTA attachment (IR spectrum of free TTA shown in the Chapter 3, Section 3.1,   
Figure 3.1) . 
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(A) 
 
(B) 
Figure 3.23. FT-IR spectra of (A) MSH4 peptide and (B) Eu:NaYF4-MSH4 
nanoparticles. 
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(C) 
Figure 3.23. FT-IR spectrum of (C) TTA coated Eu:NaYF4-MSH4 nanoparticles. 
 
  
3.7.2 UV-visible Absorption and Luminescence Studies 
MSH4 peptide shows a characteristic absorption peak at 290 nm as shown in 
Figure 3.24 (A).  The UV-visible spectrum of TTA coated Eu:NaYF4-MSH4 
nanoparticles (Figure 3.24(A)) presented this characteristic absorption band due to the 
presence of MSH4 peptide.  In addition, TTA coated Eu:NaYF4-MSH4 exhibits a peak at 
343 nm confirming the presence of TTA ligand (UV- visible spectrum of free TTA is 
shown in the Chapter 3, Section 3.1, Figure 3.2).  According to the luminescence 
spectrum (Figure 3.24(A)), the Eu(III) peak can be recognized at 614 nm upon 343 nm 
excitation.  The quantum yield for the TTA coated Eu:NaYF4-MSH4 nanoparticles is 
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calculated to be 0.4%.  This value has to be optimized by using different ligand 
combinations of MSH4/TTA.  This will be a scope of a future project. 
 
(A) 
 
(B) 
Figure 3.24. (A) UV-visible absorption spectrum and (B) luminescence spectrum of TTA 
coated Eu:NaYF4-MSH4 nanoparticles (dispersed in a methanol/ water solution). 
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3.7.3 X-Ray Powder Diffraction Studies 
The XRD spectrum of TTA coated Eu:NaYF4-MSH4 nanoparticles inveterates 
the  identical hexaganal crystal structure of Eu:NaYF4  nanoparticles as shown in Figure 
3.25.  All the diffraction positions agreed with the hexaganal structure of NaYF4 crystals.  
 
Figure 3.25. XRD spectrum of TTA coated Eu:NaYF4-MSH4 nanoparticles. 
 
3.7.4 Transmission Electron Microscope (TEM) and Scanning Electron Microscope 
Studies (SEM)    
 
 TEM and SEM images of TTA coated Eu:NaYF4-MSH4 nanoparticles are 
depicted in Figure 3.26.  The morphology of the nanoparticles is roughly spherical with 
an average particle diameter of 18 nm promising for biomedical imaging applications.  
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Figure 3.26. (A) TEM image and (B) SEM image of TTA coated Eu:NaYF4-MSH4 
nanoparticles. 
 
3.8 UPCONVERTING NANOPARTICLES 
Upconverting nanoparticles have drawn recent interest in their use in biological 
systems due to harmless infrared excitation with minimum background fluorescence.  
Upconverting nanoparticles (Yb:Er:NaYF4) were synthesized by using oleic acid as the 
surfactant.  Oleic acid was removed from the nanoparticle surface as was done in 
Eu:NaYF4 nanoparticle synthesis.  Oleic acid free Yb:Er:NaYF4 nanoparticles were freely 
dispersible in water. Bare Yb:Er:NaYF4 nanoparticles were coated with aminoethyl 
phosphate (AEP) to improve the water dispersibility and future surface functionality.  
AEP is an efficient linker for attaching the MSH4 peptide ligand.  Due to amino 
carboxylate coupling, AEP coated nanoparticles can efficiently be attached to MSH4 
peptide using peptide coupling.  
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3.8.1 Fourier Transform Infrared Studies 
IR spectrum of oleic acid coated Yb:Er:NaYF4 revealed identical peak positions 
corresponding to the oleic acid coated Eu:NaYF4 nanoparticles.  The peaks around     
1537 cm
-1
 and 1444 cm
-1
 confirmed the COO
-
 attachment of nanoparticles (Figure 
3.27(A)).  The peaks corresponding to oleic acid were diminished in the IR spectrum of 
oleic acid free Yb:Er:NaYF4 nanoparticles (Figure 3.27(B)).  The same peak observed for 
Eu:NaYF4 nanoparticles around 1653 cm
-1
 was observed in the IR spectra of oleic acid 
free Yb:Er:NaYF4 nanoparticles.   
 
(A) 
Figure 3.27. IR spectrum of (A) oleic acid coated Yb:Er:NaYF4 nanoparticles.  
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(B) 
Figure 3.27. IR spectrum of (B) oleic acid free Yb:Er:NaYF4 nanoparticles.  
 
3.8.2 X-Ray Powder Diffraction Studies 
 XRD patterns of the Yb:Er:NaYF4 nanoparticles (Figure 3.28) exhibit peak 
positions  and intensities that can be well indexed in accordance with the hexagonal 
structure of NaYF4 crystals suggesting high crystallinity of the product.  The dopant 
metal ions and levels did not change the parental crystal structure of the material. 
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(A) 
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Figure 3.28. XRD spectra of (A) oleic acid coated Yb:Er:NaYF4 nanoparticles and (B) 
AEP coated Yb:Er:NaYF4 nanoparticles. 
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3.8.3 Transmission Electron Microscope (TEM) and Scanning Electron Microscope  
Studies (SEM)    
 The high resolution TEM image shows spherical morphology of the 
Yb:Er:NaYF4-AEP nanoparticles with an average particle diameter of 19 nm.  According 
to the TEM image, particle diameter distribution was presented in Figure 3.30.  Forty six 
percent of the nanoparticles have a diameter of 20 nm.   
  
Figure 3.29. (A) TEM image and (B) SEM image of Yb:Er:NaYF4-AEP nanoparticles.  
 
  
Figure 3.30.  Particles diameter distribution of Yb:Er:NaYF4-AEP nanoparticles obtained 
from the TEM image. 
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3.9 CONCLUSIONS 
In this project, the luminescence properties, hydrophilicity, and the selectivity of 
nanoparticles to melanoma cancer cell-surface receptors were optimized focusing on two 
nanoparticle systems: europium-based down-converting nanoparticles and ytterbium-, 
erbium-based upconverting nanoparticles.  The nanomaterials were characterized using 
different analytical techniques to confirm the crystal structures and the surface 
functionalization. 
We hypothesized that the luminescence characteristics of europium-based 
nanoparticles could be improved by using a sensitization process.  Our synthetic strategy 
was to functionalize the surface of the nanomaterials with a chelator ligand (namely 
TTA) with strong light absorption properties.  We have explored two synthetic methods 
for introducing the TTA ligand to the nanoparticle surface.  We utilized a ligand 
exchange method with LaEuF3 nanoparticles.  With the second nanoparticles system, 
Eu:NaYF4, we modified a synthetic method to remove the pre-existing oleic acid ligands 
before introducing the TTA ligands.  
In this work, we have confirmed that our sensitizer ligand, TTA is capable of 
significantly enhancing the Eu(III)-based luminescence at 614 nm upon surface 
functionalization of the nanoparticles.  The surface modified Eu(III)-based nanoparticles  
with TTA ligand show characteristic light absorption in the UV region with intense 
luminescence as a result of the energy transfer from TTA ligand to the Eu(III)-based 
excited states.  We have observed relatively higher quantum yield values for the smaller 
sized nanoparticles (Eu:NaYF4, 15-20 nm) compared to those observed for large particles 
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(LaEuF3, 100-150 nm) indicating that efficient ligand-to-metal energy transfer is a 
distance dependent.  We believe that the smaller sized nanoparticles have an optimal 
distance between most of the Eu(III) ions and the TTA ligand warranting an efficient 
energy transfer and a higher luminescence efficiency.  In addition, NaYF4 matrix 
produced highly crystalline nanoparticles compared to the low crystallinity of the LaF3 
matrix.  Highly crystalline nanoparticles promise fewer crystal defects which may reduce 
the luminescence quenching processes.  This may also contribute to the observed higher 
luminescence quantum yields of the NaYF4 nanoparticles. 
Luminescence quantum yield of the LaEuF3-(AEP)-TTA nanoparticles increased 
with the increment of the TTA amount used for the ligand exchange process.  Our TGA 
results confirmed a higher surface coverage of TTA with increasing the initial amount of 
TTA used in the ligand exchange process.  Attachment of a higher amount of 
chromophore ligand resulted an enhanced sensitization process.  This may be a reason for 
the increment of the observed luminescence quantum yield of the LaEuF3-(AEP)-TTA 
nanoparticles where 32 mg of TTA was used for the ligand exchange process.  However 
no significant increase in the luminescence quantum yield (from 32 mg of TTA) was 
observed when 64 mg of TTA ligand was used in the synthesis.  This may be due to the 
surface saturation above 32 mg of TTA ligand as observed in our TGA measurements.  
When LaEuF3-(AEP)-TTA (using 32 mg of TTA) nanoparticle system (with a 
quantum yield of 4.0 %) was compared with LaEuF3-(Citric acid)-TTA (32 mg of TTA) 
nanoparticle system, citric acid coated nanoparticles exhibited a lower quantum yield 
value (1.9%).  Citric acid has multiple coordination sites (carboxylic groups) compared to 
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the single bidentate phosphate binding site of AEP.  According to these structural 
features, citric acid may be strongly bound to the nanoparticle surface compared to AEP.  
Thus AEP molecules can easily be replaced by TTA ligands opposed to the strongly 
bound citric acid molecules during the ligand exchange process.  Therefore we assume 
that the ligand exchange process may not be efficient with citric acid coated nanoparticles 
resulting a lower amount of TTA molecules on the surface of LaEuF3-(Citric acid)-TTA 
nanoparticles.  This might have reduced the sensitization efficiency resulting a lower 
luminescence quantum yield.  
When LaEuF3-(AEP)-TTA (32 mg) nanoparticle system (quantum yield of 4.0 %) 
was compared with LaEuF3-(AEP)-HFA (32 mg) nanoparticle system, HFA coated 
nanoparticles exhibited a very low quantum yield value (0.78%).  The electronic energy 
difference between the triplet level of the sensitizer ligand and the 
5
D0 energy level of 
Eu(III) ion is crucial for the ligand-to-metal sensitization process.
34
  The triplet level 
energy of the HFA ligand and the TTA ligand is at 22 000 cm
-1
 and 20 000 cm
-1
, 
respectively.
34
  The energy of the 
5
D0 state of Eu(III) ion was found to be at 17 500 cm
-1
.  
The energy gap between triplet state of the HFA ligand and 
5
D0 state of Eu(III) ion is 4 
500 cm
-1
.  The energy gap between TTA and 
5
D0 state of Eu(III) ion is 2500 cm
-1
.  We 
believe that an energy gap of 2500 cm
-1
 may be optimum for an efficient energy transfer 
between the ligand and the Eu(III) ions based on our luminescence quantum yield 
measurements.  Thus, a relatively large energy gap of 4500 cm
-1
 may reduce the 
sensitization efficiency in LaEuF3-(AEP)-HFA nanoparticles resulting a poor 
luminescence quantum yield. 
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When Eu:NaYF4-TTA nanoparticle system (with a luminescence quantum yield 
of 17.0 %) is compared with Eu:NaYF4-btfa nanoparticle system, Eu:NaYF4-btfa (32 mg) 
nanoparticles have a lower luminescence  quantum yield (4.2%).  The triplet energy of 
the btfa ligand is at 21 400 cm
-1
.  The energy gap between the triplet state of the btfa 
ligand and 
5
D0 state of Eu(III) ion is 3900 cm
-1
.  This energy gap is larger than the energy 
gap between TTA ligand and Eu(III) ions (2500 cm
-1
).  Therefore the observed 
luminescence quantum yield of the Eu:NaYF4-btfa nanoparticles are lower than that of 
Eu:NaYF4-TTA nanoparticles. 
The surface of the upconverting nanoparticles were functionalized with AEP 
ligand for improving the hydrophilicity.  The AEP ligand was introduced after removing 
the preexisting oleic acid ligands using an identical synthetic strategy that we utilized for 
removing oleic acid in Eu:NaYF4 nanoparticles.  The AEP-modified nanoparticles can 
readily be dispersed in nanopure water (up to about 2 mg in 0.5 mL of water).  
We have initialized the labeling of nanoparticles with MSH4 ligand for future in 
vitro assay studies with melanoma cells expressing human melanocortin receptors.  The 
preliminary characterization data promises the MSH4 peptide attachment to the 
nanoparticle surface.  Modification of the linker length between the nanoparticle surface 
and the peptide ligand to enhance the selectivity will be a future project.  We also plan to 
optimize the luminescence quantum yield of the MSH4-TTA-coated nanoparticles by 
varying TTA / MSH4 ratio in the nanoparticles.  Once fully optimized, the nanoparticles 
synthesized in this project have potential applications for carrying out in vitro and in vivo 
cell binding assays for screening of melanoma cancer targeted pharmaceuticals.  
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